Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol for hemodynamic effects during gastrointestinal endoscopy in elderly patients
ChiCTR2200060474Phase 4Not yet recruiting
- Sponsor
- Shidong Hospital
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in None comparing remimazolam group with propofol group (2 arms). Primary endpoints: blood pressure and heart rate. Planned start May 2022; status: not yet recruiting.
02
Drugs
remimazolampropofol
Beyond the preview
Go deeper on ChiCTR2200060474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200060474.